arrow
李博 封面图

李博 (Bo Li)

naval medical university访问学者
H指数:36
被引数:4,411

个人简介

"1、教育经历 (1) 2008/03-2012/06, 江南大学,食品学院,博士 (2) 2000/09-2003/07, 中国药科大学,药学院,硕士 (3) 1994/09-1998/06, 中国药科大学,药学院,学士 2、工作经历 (1) 2003/07 至今, 中国药科大学, 药学院, 教师 (2014/08-2015/09, University of Massachusetts, Amherst, Department of Food Science, 访问学者) (2) 1998/07-2000/08, 华北制药集团, 技术员 (1) 药物质量控制关键技术 (2) 大分子药物分析 1、科研项目 主持国家自然科学基金1项、中央高校科研专项基金2项;参与十三五国家重点研发计划、十二五国家重大新药创制专项、江苏省自然科学基金2项。 主持和参与企业委托项目40余项。 1.Yang, T., Yue, G., Ge, Y., Zhang, Y., Xu, P., Wang, Y., Li, B.*, & Di, B.* (2022). SCH 23390 inhibits the acquisition of nitrous oxide-induced conditioned place preference and the changes in ERK phosphorylation expression in nucleus accumbens of mice. Neuroscience letters, 781, 136674. 2.Abdulbagi, M., Wang, L., Siddig, O., Di, B.*, & Li, B.* (2021). D-Amino Acids and D-Amino Acid-Containing Peptides: Potential Disease Biomarkers and Therapeutic Targets?. Biomolecules, 11(11), 1716. 3.Tan, B., Zhang, X., Quan, X., Zheng, G., Li, X., Zhao, L.*, Li, W.*, & Li, B.* (2020). Design, synthesis and biological activity evaluation of novel 4-((1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl) oxy) pyridine-2-yl) amino derivatives as potent transforming growth factor-β (TGF-β) type I receptor inhibitors. Bioorganic & medicinal chemistry letters, 30(16), 127339. 4.Wang, M., Niu, A., Gong, Z., Xu, Z., Li, L., Li, B.*, & Wang, J.* (2020). PEG-amino acid-przewaquinone a conjugations: Synthesis, physicochemical properties and protective effect in a rat model of brain ischemia-reperfusion. Bioorganic & medicinal chemistry letters, 30(1), 126780. 5.Li, Z., Zhang, Z., Chen, Y., Tang, S., Lin, T., Huang, J., Li, B.*, & Jiang, C.* (2019). Design, synthesis and evaluation of d-amino acid-containing peptidomimetics targeting the polo-box domain of polo-like kinase 1. Bioorganic chemistry, 85, 534–540. 6.Xu, N., Shanbhag, A. G., Li, B., Angkuratipakorn, T., & Decker, E. A. (2019). Impact of Phospholipid-Tocopherol Combinations and Enzyme-Modified Lecithin on the Oxidative Stability of Bulk Oil. Journal of agricultural and food chemistry, 67(28), 7954–7960. 7.Phil, L., Naveed, M., Mohammad, I. S., Bo, L.*, & Bin, D.* (2018). Chitooligosaccharide: An evaluation of physicochemical and biological properties with the proposition for determination of thermal degradation products. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 102, 438–451. 8.Yang, Y., Lian, Y., Zhong, P., Wang, D., Di, B.*, & Li, B.* (2018). Characterization and quantitative analysis of related substances in Coenzyme A by HPLC and LC-MS/MS. Journal of pharmaceutical and biomedical analysis, 150, 220–232. 9.Li, B., Zhang, J., Bu, F., & Xia, W.* (2013). Determination of chitosan with a modified acid hydrolysis and HPLC method. Carbohydrate research, 366, 50–54. 10.Li, B., Zhang, J., Dai, F., & Xia, W.* (2012). Purification of Chitosan by Using Sol-gel Immobilized Pepsin Deproteinization, Carbohydrate Polymers, 88, 206-212."

教育背景

  • 2008.03 – 2012.06

    江南大学 博士 食品学院

  • 2000.09 – 2003.07

    中国药科大学 硕士 药学院

  • 1994.09 – 1998.06

    中国药科大学 学士 药学院

工作经历

  • 2014.08 – 2015.09

    University of Massachusetts, Amherst, Department of Food Science

    访问学者

  • 2003.07 – 至今

    中国药科大学

    教师

  • 1998.07 – 2000.08

    华北制药集团

    技术员

荣誉奖项

暂无内容

Reduced recurrence rate with a targeted approach in uncomplicated appendicitis treated with endoscopic direct vs retrograde therapy

靶向方法治疗无并发症阑尾炎时,内镜直视法与逆行法治疗的复发率降低

2025-11-140
PRE